Risk of herpes zoster following mRNA COVID-19 vaccine administration

References

• Centers for Disease Control and Prevention. Shingles (Herpes Zoster) 2022 [cited 2022 Dec 1]. Available from: https://www.cdc.gov/shingles/index.html
   Google Scholar
• Dooling KL, Guo A, Patel M, et al. Recommendations of the advisory committee on immunization practices for use of herpes zoster vaccines. MMWR Morb Mortal Wkly Rep. 2018;67(3):103–108. doi: 10.15585/mmwr.mm6703a5
   PubMed Web of Science ®Google Scholar
• Anderson TC, Masters NB, Guo A, et al. Use of recombinant zoster vaccine in immunocompromised adults aged≥ 19 years: recommendations of the Advisory Committee on Immunization Practices—United States, 2022. MMWR Morb Mortal Wkly Rep. 2022;71(3):80–84. doi: 10.15585/mmwr.mm7103a2
   PubMed Web of Science ®Google Scholar
• Furer V, Zisman D, Kibari A, et al. Herpes zoster following BNT162b2 mRNA COVID-19 vaccination in patients with autoimmune inflammatory rheumatic diseases: a case series. Rheumatology. 2021;60(SI):SI90–SI95. doi: 10.1093/rheumatology/keab345
   PubMed Web of Science ®Google Scholar
• David E, Landriscina A. Herpes Zoster following COVID-19 vaccination. J Drugs Dermatol. 2021;20(8):898–900. doi: 10.36849/JDD.6146
   PubMed Web of Science ®Google Scholar
• Rodríguez-Jiménez P, Chicharro P, Cabrera L-M, et al. Varicella-zoster virus reactivation after SARS-CoV-2 BNT162b2 mRNA vaccination: report of 5 cases. JAAD Case Rep. 2021;12:58–59. doi: 10.1016/j.jdcr.2021.04.014
   PubMedGoogle Scholar
• Akpandak I, Miller DC, Sun Y, et al. Assessment of herpes zoster risk among recipients of COVID-19 vaccine. JAMA Netw Open. 2022;5(11):e2242240–e2242240. doi: 10.1001/jamanetworkopen.2022.42240
   PubMed Web of Science ®Google Scholar
• Birabaharan M, Kaelber DC, Karris MY. Risk of herpes zoster reactivation after messenger RNA COVID-19 vaccination: a cohort study. J Am Acad Dermatol. 2022; 87(3):649–651. doi: 10.1016/j.jaad.2021.11.025
   PubMed Web of Science ®Google Scholar
• Barda N, Dagan N, Ben-Shlomo Y, et al. Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting. N Engl J Med. 2021;385(12):1078–1090. doi: 10.1056/NEJMoa2110475
   PubMed Web of Science ®Google Scholar
• Koebnick C, Langer-Gould AM, Gould MK, et al. Sociodemographic characteristics of members of a large, integrated health care system: comparison with US Census Bureau data. Perm J. 2012;16(3):37–41. doi: 10.7812/tpp/12-031
   PubMedGoogle Scholar
• California Department of Public Health. California COVID-19 vaccination program provider operations manual [cited 2022 Dec 1]. Available from: https://eziz.org/assets/docs/COVID19/IMM-1425.pdf
   Google Scholar
• Thonginnetra S, Limtanyakul P, Tawinprai K. Herpes zoster after COVID-19 vaccination in an adolescent. Dermatol Online J. 2022;28(4). doi: 10.5070/D328458533
   PubMedGoogle Scholar
• Gringeri M, Battini V, Cammarata G, et al. Herpes zoster and simplex reactivation following COVID-19 vaccination: new insights from a vaccine adverse event reporting system (VAERS) database analysis. Expert Rev Vaccines. 2022;21(5):675–684. doi: 10.1080/14760584.2022.2044799
   PubMed Web of Science ®Google Scholar
• Desai HD, Sharma K, Shah A, et al. Can SARS-CoV-2 vaccine increase the risk of reactivation of Varicella zoster? A systematic review. J Cosmet Dermatol. 2021;20(11):3350–3361. doi: 10.1111/jocd.14521
   PubMed Web of Science ®Google Scholar
• Chu C-W, Jiesisibieke ZL, Yang Y-P, et al. Association of COVID-19 vaccination with herpes zoster: a systematic review and meta-analysis. Expert Rev Vaccines. 2022;21(5):601–608. doi: 10.1080/14760584.2022.2036128
   PubMed Web of Science ®Google Scholar
• Hertel M, Heiland M, Nahles S, et al. Real-world evidence from over one million COVID-19 vaccinations is consistent with reactivation of the varicella-zoster virus. J Eur Acad Dermatol Venereol. 2022;36(8):1342–1348. doi: 10.1111/jdv.18184
   PubMed Web of Science ®Google Scholar
• Chen YC, Ho CH, Liu TH, et al. Long-term risk of herpes zoster following COVID-19: a retrospective cohort study of 2 442 686 patients. J med virol. 2023 Apr;95(4):e28745. PubMed PMID: 37185849; eng. doi: 10.1002/jmv.28745
   PubMed Web of Science ®Google Scholar
• Bhavsar A, Lonnet G, Wang C, et al. Increased Risk of Herpes Zoster in Adults ≥50 Years Old Diagnosed with COVID-19 in the United States. Open Forum Infect Dis. 2022 May;9(5):ofac118. doi: 10.1093/ofid/ofac118. PubMed PMID: 35392454; PubMed Central PMCID: PMCPMC8982770.
   PubMed Web of Science ®Google Scholar
• Zerboni L, Sen N, Oliver SL, et al. Molecular mechanisms of varicella zoster virus pathogenesis. Nature Rev Microbiol. 2014;12(3):197–210. doi: 10.1038/nrmicro3215
   PubMed Web of Science ®Google Scholar
• Martinez-Reviejo R, Tejada S, Adebanjo GAR, et al. Varicella-Zoster virus reactivation following severe acute respiratory syndrome coronavirus 2 vaccination or infection: new insights. Eur J Internal Med. 2022;104:73–79. doi: 10.1016/j.ejim.2022.07.022
   PubMed Web of Science ®Google Scholar
• Wan EYF, Chui CSL, Wang Y, et al. Herpes zoster related hospitalization after inactivated (CoronaVac) and mRNA (Bnt162b2) SARS-CoV-2 vaccination: a self-controlled case series and nested case-control study. Lancet Reg Health - West Pac. 2022;21:100393. doi: 10.1016/j.lanwpc.2022.100393
   PubMedGoogle Scholar
• Lu P-J, Hung M-C, Srivastav A, et al. Surveillance of vaccination coverage among adult populations—United States, 2018. MMWR Surveill Summ. 2021;70(SS–3):1–26. doi: 10.15585/mmwr.ss7003a1
   PubMed Web of Science ®Google Scholar
• National Committee for Quality Assurance. Adult Immunization Status (AIS). 2023 [cited 2023 Feb 23]. Available from: https://www.ncqa.org/hedis/measures/adult-immunization-status/
   Google Scholar
• Beatty AL, Peyser ND, Butcher XE, et al. Analysis of COVID-19 vaccine type and adverse effects following vaccination. JAMA Netw Open. 2021;4(12):e2140364. doi: 10.1001/jamanetworkopen.2021.40364
   PubMed Web of Science ®Google Scholar
• Tseng HF, Bruxvoort K, Ackerson B, et al. The epidemiology of herpes zoster in immunocompetent, unvaccinated adults ≥50 years old: incidence, complications, hospitalization, mortality, and recurrence. J Infect Dis. 2019;222(5):798–806. doi: 10.1093/infdis/jiz652
   Web of Science ®Google Scholar
• Xu S, Glenn S, Sy L, et al. Impact of the COVID-19 pandemic on health care utilization in a large integrated health care system: retrospective cohort study. J Med Internet Res. 2021;23(4):e26558. doi: 10.2196/26558
   PubMed Web of Science ®Google Scholar